Skip to main content

Advertisement

Log in

Actigraphy-measured rest-activity circadian rhythm disruption in patients with advanced cancer: a scoping review

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Patients with later-stage cancer have been reported to demonstrate more disrupted rest-activity circadian rhythms (RACR) than those with earlier-stage cancer, but consolidated evidence of this is lacking. The aim of this review was to examine and map the existing evidence on actigraphy-measured RACR in terms of their (1) pattern, (2) prevalence, (3) related factors, and (4) outcomes in advanced cancer patients.

Methods

A comprehensive scoping review was conducted using Arksey and O’Malley’s framework. A literature search was performed using nine databases: MEDLINE, Embase, PsycINFO, CINAHL, British Nursing Index, Cochrane Library, Scopus, Web of Science, and SINTA.

Results

Twenty-one studies were included in the review. Compared with the healthy population, advanced cancer patients were more likely to display weaker RACR, manifesting as lower activity levels during the day, more frequent and longer daytime naps, and fragmented nighttime sleep. The prevalence of RACR disruption among advanced cancer patients ranged from 31.3 to 54.9%. It was found to be linked to the presence of physical and psychological symptoms (fatigue, appetite loss, pain, dyspnoea, sleep disturbance, depression, and anxiety), chemotherapy, male sex, and also predict the lower quality of life and survival.

Conclusion

Disruption of the RACR is prevalent in advanced cancer patients and is associated with a set of physical and psychological symptoms. It was also found to be a predictor of the quality of life and survival among these patients. These results indicate the importance of interventions to restabilise the disrupted RACR among advance cancer patients to improve their health outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

Data and material are available.

Code availability

N/A

References

  1. Czeisler CA, Duffy JF, Shanahan TL et al (1999) Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 284:2177–2181. https://doi.org/10.1126/science.284.5423.2177

    Article  CAS  PubMed  Google Scholar 

  2. Masri S, Sassone-Corsi P (2018) The emerging link between cancer, metabolism, and circadian rhythms. Nat Med 24:1795–1803. https://doi.org/10.1038/s41591-018-0271-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sulli G, Lam MTY, Panda S (2019) Interplay between circadian clock and cancer: new frontiers for cancer treatment. Trends in Cancer 1:20. https://doi.org/10.1016/j.trecan.2019.07.002

    Article  CAS  Google Scholar 

  4. Chang WH, Lai AG (2019) Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies. J Transl Med 17:1–16. https://doi.org/10.1186/s12967-019-1880-9

    Article  CAS  Google Scholar 

  5. Shilts J, Chen G, Hughey JJ (2018) Evidence for widespread dysregulation of circadian clock progression in human cancer. PeerJ 6:e4327. https://doi.org/10.7717/peerj.4327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ballesta A, Innominato PF, Dallmann R et al (2017) Systems chronotherapeutics. Pharmacol Rev 69:161–199. https://doi.org/10.1124/pr.116.013441

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Schwartz WJ, Klerman EB (2019) Circadian neurobiology and the physiologic regulation of sleep and wakefulness. Neurol Clin 37:475–486. https://doi.org/10.1016/j.ncl.2019.03.001

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rosenwasser A, Wirz-Justice A (1997) Circadian rhythms and depression: clinical and experimental models. In: Redfern P, Lemmer B (eds) Physiology and Pharmacology of Biological Rhythms. Springer-Verlag, Berlin, pp 457–485

    Chapter  Google Scholar 

  9. Mormont M, Lévi F (1997) Circadian-system alterations during cancer processes: a review. Int J Cancer 70:241–247. https://doi.org/10.1002/(SICI)1097-0215(19970117)70:2%3c241::AID-IJC16%3e3.0.CO;2-L

    Article  CAS  PubMed  Google Scholar 

  10. Ancoli-Israel S, Cole R, Alessi C et al (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26:342–392. https://doi.org/10.1093/sleep/26.3.342

    Article  PubMed  Google Scholar 

  11. Huang C, Madsen MT, Gögenur I (2015) Circadian rhythms measured by actigraphy during oncological treatments: a systematic review. Biol Rhythm Res 46:329–348. https://doi.org/10.1080/09291016.2015.1004840

    Article  Google Scholar 

  12. Eismann EA, Lush E, Sephton SE (2010) Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology 35:963–976. https://doi.org/10.1016/j.psyneuen.2009.12.011

    Article  CAS  PubMed  Google Scholar 

  13. Mormont WJ, Bleuzen P et al (2000) Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6:3038–3045

    CAS  PubMed  Google Scholar 

  14. Lévi F, Dugué PA, Innominato P et al (2014) Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int 31:891–900. https://doi.org/10.3109/07420528.2014.924523

    Article  PubMed  Google Scholar 

  15. Grutsch JF, Wood PA, Du-Quiton J et al (2011) Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer. J Circadian Rhythms 9:4. https://doi.org/10.1186/1740-3391-9-4

    Article  PubMed  PubMed Central  Google Scholar 

  16. Innominato P, Komarzynski S, Palesh OG et al (2018) Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer. Cancer Med 7:4396–4405. https://doi.org/10.1002/cam4.1711

    Article  PubMed  PubMed Central  Google Scholar 

  17. Munn Z, Peters MDJ, Stern C et al (2018) Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol 18:1–7. https://doi.org/10.1186/s12874-018-0611-x

    Article  Google Scholar 

  18. Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract 8:19–32. https://doi.org/10.1080/1364557032000119616

    Article  Google Scholar 

  19. Tricco AC, Lillie E, Zarin W et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467–473. https://doi.org/10.7326/M18-0850

    Article  PubMed  Google Scholar 

  20. Vetter C (2018) Circadian disruption: what do we actually mean? Eur J Neurosci 1:20. https://doi.org/10.1111/ejn.14255

    Article  Google Scholar 

  21. National Cancer Institute (2019) NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/advanced-cancer. Accessed 24 Oct 2019

  22. Smith MT, McCrae CS, Cheung J et al (2018) Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders. J Clin Sleep Med 14:1209–1230. https://doi.org/10.5664/jcsm.7228

    Article  PubMed  PubMed Central  Google Scholar 

  23. Du-Quiton J, Wood PA, Burch JB et al (2010) Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psychooncology 19:180–189. https://doi.org/10.1002/pon.1539

    Article  PubMed  Google Scholar 

  24. Fujisawa D, Temel JS, Greer JA et al (2019) Actigraphy as an assessment of performance status in patients with advanced lung cancer. Palliat Support Care 17:574–578. https://doi.org/10.1017/S1478951518001074

    Article  PubMed  Google Scholar 

  25. Grutsch JF, Ferrans C, Wood PA, et al (2011) The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer 11https://doi.org/10.1186/1471-2407-11-193

  26. R.D. L, M.A. D, J.F. G, et al (2005) Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer 93:1202–1208. https://doi.org/10.1038/sj.bjc.6602859

    Article  Google Scholar 

  27. Mormont MC, Waterhouse J (2002) Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Int 19:313–323. https://doi.org/10.1081/CBI-120002606

    Article  PubMed  Google Scholar 

  28. Ortiz-Tudela E, Iurisci I, Beau J et al (2014) The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy. Int J Cancer 134:2717–2725. https://doi.org/10.1002/ijc.28587

    Article  CAS  PubMed  Google Scholar 

  29. Ortiz-Tudela E, Innominato PF, Rol MA, et al (2016) Relevance of internal time and circadian robustness for cancer patients. BMC Cancer 16https://doi.org/10.1186/s12885-016-2319-9

  30. Palesh O, Haitz K, Lévi F et al (2017) Relationship between subjective and actigraphy-measured sleep in 237 patients with metastatic colorectal cancer. Qual Life Res 26:2783–2791. https://doi.org/10.1007/s11136-017-1617-2

    Article  PubMed  PubMed Central  Google Scholar 

  31. Rich T, Innominato PF, Boerner J et al (2005) Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 11:1757–1764. https://doi.org/10.1158/1078-0432.CCR-04-2000

    Article  CAS  PubMed  Google Scholar 

  32. Bernatchez MS, Savard J, Ivers H (2017) Disruptions in sleep–wake cycles in community- dwelling cancer patients receiving palliative care and their correlates. Chronobiol Int. https://doi.org/10.1080/07420528.2017.1381615Disruptions

    Article  PubMed  Google Scholar 

  33. Innominato P, Lim AS, Palesh O et al (2016) The effect of melatonin on sleep and quality of life in patients with advanced breast cancer. Support Care Cancer 24:1097–1105. https://doi.org/10.1007/s00520-015-2883-6

    Article  PubMed  Google Scholar 

  34. Fouladiun M, Korner U, Gunnebo L et al (2007) Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. Clin Cancer Res 13:6379–6385. https://doi.org/10.1158/1078-0432.CCR-07-1147

    Article  CAS  PubMed  Google Scholar 

  35. Ma CL, Chang WP, Lin CC (2014) Rest/activity rhythm is related to the coexistence of pain and sleep disturbance among advanced cancer patients with pain. Support Care Cancer 22:87–94. https://doi.org/10.1007/s00520-013-1918-0

    Article  PubMed  Google Scholar 

  36. Innominato PF, Mormont MC, Rich TA et al (2009) Circadian disruption, fatigue, and anorexia clustering in advanced cancer patients: implications for innovative therapeutic approaches. Integr Cancer Ther 8:361–370. https://doi.org/10.1177/1534735409355293

    Article  PubMed  Google Scholar 

  37. Innominato FC, Gorlia T et al (2009) Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res 69:4700–4707. https://doi.org/10.1158/0008-5472.CAN-08-4747

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Innominato PF, Giacchetti S, Bjarnason GA et al (2012) Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer. Int J cancer 131:2684–2692. https://doi.org/10.1002/ijc.27574

    Article  CAS  PubMed  Google Scholar 

  39. Natale V, Innominato PF, Boreggiani M et al (2015) The difference between in bed and out of bed activity as a behavioral marker of cancer patients: a comparative actigraphic study. Chronobiol Int 32:925–933. https://doi.org/10.3109/07420528.2015.1053909

    Article  PubMed  Google Scholar 

  40. Levin RD, Daehler MA, Grutsch JF et al (2005) Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer 93:1202–1208

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Mormont MC, Langouët AM, Claustrat B et al (2002) Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status. Chronobiol Int 19:141–155. https://doi.org/10.1081/CBI-120002593

    Article  PubMed  Google Scholar 

  42. Bernatchez MS, Savard J, Ivers H (2018) Disruptions in sleep-wake cycles in community-dwelling cancer patients receiving palliative care and their correlates. Chronobiol Int 35:49–62. https://doi.org/10.1080/07420528.2017.1381615

    Article  PubMed  Google Scholar 

  43. Innominato GS, Bjarnason G et al (2012) Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer. Int J Cancer 131:2684–2692. https://doi.org/10.1002/ijc.27574

    Article  CAS  PubMed  Google Scholar 

  44. Roenneberg T, Merrow M (2016) The circadian clock and human health. Curr Biol 26:R432–R443. https://doi.org/10.1016/j.cub.2016.04.011

    Article  CAS  PubMed  Google Scholar 

  45. Swaminathan K, Klerman EB, Phillips AJK (2017) Are individual differences in sleep and circadian timing amplified by use of artificial light sources? J Biol Rhythms 32:165–176. https://doi.org/10.1177/0748730417699310

    Article  PubMed  PubMed Central  Google Scholar 

  46. Gnocchi D, Bruscalupi G (2017) Circadian rhythms and hormonal homeostasis: pathophysiological implications. Biology (Basel) 6:10. https://doi.org/10.3390/biology6010010

    Article  CAS  Google Scholar 

  47. Paulsen Ø, Laird B, Aass N et al (2017) The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer. PLoS ONE 12:e0177620. https://doi.org/10.1371/journal.pone.0177620

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Samuelsson LB, Bovbjerg DH, Roecklein KA, Hall MH (2018) Sleep and circadian disruption and incident breast cancer risk: an evidence-based and theoretical review. Neurosci Biobehav Rev 84:35–48. https://doi.org/10.1016/j.neubiorev.2017.10.011

    Article  PubMed  Google Scholar 

  49. Calderon C, Carmona-Bayonas A, Hernandez R et al (2019) Incidence of sleep problems and their mediating role on depression and anxious preoccupation in patients with resected, non-advanced cancer: data from NEOcoping study. Clin Transl Oncol 21:1104–1107. https://doi.org/10.1007/s12094-018-02018-2

    Article  CAS  PubMed  Google Scholar 

  50. Hickie IB, Naismith SL, Robillard R, et al (2013) Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression. BMC Med 11. https://doi.org/10.1186/1741-7015-11-79

  51. Frank E, Benabou M, Bentzley B et al (2014) Influencing circadian and sleep-wake regulation for prevention and intervention in mood and anxiety disorders: what makes a good homeostat? Ann N Y Acad Sci 1334:1–25. https://doi.org/10.1111/nyas.12600

    Article  PubMed  PubMed Central  Google Scholar 

  52. Golombek DA, Rosenstein RE (2010) Physiology of circadian entrainment. Physiol Rev 90:1063–1102. https://doi.org/10.1152/physrev.00009.2009

    Article  CAS  PubMed  Google Scholar 

  53. Dijk D-J, Archer SN (2009) Light, sleep, and circadian rhythms: together again. PLoS Biol 7:e1000145. https://doi.org/10.1371/journal.pbio.1000145

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Kronish IM, Cheung YK, Julian J et al (2019) Clinical usefulness of bright white light therapy for depressive symptoms in cancer survivors: results from a series of personalized (N-of-1) trials. Healthcare 8:10. https://doi.org/10.3390/healthcare8010010

    Article  PubMed Central  Google Scholar 

  55. Garland SN, Johnson JA, Carlson LE et al (2020) Light therapy for insomnia symptoms in fatigued cancer survivors: a secondary analysis of a randomized controlled trial. J Psychosoc Oncol Res Pract 2:e27. https://doi.org/10.1097/or9.0000000000000027

    Article  Google Scholar 

  56. Starreveld DEJ, Daniels LA, Valdimarsdottir HB et al (2018) Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial. BMC Cancer 18:1–11. https://doi.org/10.1186/s12885-018-4746-2

    Article  Google Scholar 

  57. Lévi F, Zidani R, Misset JL (1997) Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 350:681–686. https://doi.org/10.1016/S0140-6736(97)03358-8

    Article  PubMed  Google Scholar 

  58. Lévi FA, Zidani R, Vannetzel JM et al (1994) Chronomodulated versus fixed-infusion - rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst 86:1608–1617. https://doi.org/10.1093/jnci/86.21.1608

    Article  PubMed  Google Scholar 

  59. Parker KP, Bliwise DL, Ribeiro M et al (2008) Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol 26:2464–2472. https://doi.org/10.1200/JCO.2007.12.2135

    Article  PubMed  Google Scholar 

  60. BaHammam AS, Gozal D (2012) Qur’anic insights into sleep. Nat Sci Sleep 4:81–87

    Article  PubMed  PubMed Central  Google Scholar 

  61. Zhang T, Yan L, Ma S, He J (2016) Human biological rhythm in traditional Chinese medicine. J Tradit Chinese Med Sci 3:206–211. https://doi.org/10.1016/j.jtcms.2016.12.004

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study conception and design: A.M., D.N.S.C., W.K.W.S.

Data acquisition: A.M., C.L.

Data analysis and interpretation: A.M., C.L., D.N.S.C., W.K.W.S.

Manuscript writing and finalisation: A.M., D.N.S.C., W.K.W.S., C.L.

Corresponding author

Correspondence to Ariesta Milanti.

Ethics declarations

Ethics approval

N/A, no human subject is involved.

Consent to participate

N/A

Consent for publication

All authors have consented to publication.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix

Appendix

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Milanti, A., Chan, D.N.S., Li, C. et al. Actigraphy-measured rest-activity circadian rhythm disruption in patients with advanced cancer: a scoping review. Support Care Cancer 29, 7145–7169 (2021). https://doi.org/10.1007/s00520-021-06317-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-021-06317-3

Keywords

Navigation